STAT

AUGUST 22, 2024

If you’d told Jim Wilson three years ago that he’d be stepping down as director of the University of Pennsylvania’s storied Gene Therapy Program, he wouldn’t have believed you. And yet he’s now doing exactly that. Wilson, a gene therapy pioneer who has spent decades devising ways to deliver functional copies of missing or defective genes to patients, recently announced that he’s leaving Penn to found a pair of companies focused on developing gene therapi

Drug Development 348

Drug Development 348

PharmaVoice

AUGUST 22, 2024

Greg Friberg and James Sabry will take over, respectively, as heads of R&D and business development, less than a year after BioMarin named a new CEO.

130

130

STAT

AUGUST 22, 2024

WASHINGTON — U.S. regulators approved  updated Covid-19 vaccines  on Thursday, shots designed to more closely target recent virus strains — and hopefully whatever variants cause trouble this winter, too. With the Food and Drug Administration’s clearance, Pfizer and Moderna are set to begin shipping millions of doses. A third U.S. manufacturer, Novavax, expects its updated vaccine version to be available a little later.

Vaccines 352

Vaccines 352

PharmaVoice

AUGUST 22, 2024

There’s no link between revenue and R&D from smaller biotechs, and that’s where most innovation comes from, according to new studies.

130

130

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Communication

STAT

AUGUST 22, 2024

LONDON — Leqembi, the Alzheimer’s treatment from Eisai and Biogen, has hit another roadblock reaching patients in Europe.  In draft guidance, the U.K.’s cost-effectiveness watchdog on Thursday said that the limited benefits of the drug, also called lecanemab , do not justify its costs, citing not just the price of the treatment but the related expenses of administering it and monitoring for side effects.

Drug Development 345

Drug Development 345

Outsourcing Pharma

AUGUST 22, 2024

H1's decision to partner with GRM for this critical initiative in Ukraine was driven by a strong commitment to harness the power of global healthcare networks to provide humanitarian aid in regions that need it most.

109

109

Pharmaceutical Commerce

AUGUST 22, 2024

In the final part of his Pharma Commerce video interview, Matt Hawkins, CaryHealth’s Chief Technology Officer, comments on the importance of mitigating security risks, along with ways to take action.

105

105

STAT

AUGUST 22, 2024

Buzzy gene-editing startup Tome Biosciences is floundering, just nine months after launching with $213 million in funding, according to several sources with direct knowledge of the matter. One person with knowledge of the situation told STAT that Tome is winding down operations altogether and seeking a buyer by Nov. 1. Another source reported that there are still options on the table to keep the biotech running.

329

329

BioPharma Dive

AUGUST 22, 2024

The approval of both reformulated messenger RNA vaccines, which are designed to target the KP.2 virus strain, comes just ahead of the fall and winter seasons.

Vaccines 110

Vaccines 110

STAT

AUGUST 22, 2024

The pharmaceutical industry has long operated on a one-size-fits-all model, developing drugs primarily tested on, and thus best suited for, people of European descent. This approach ignores — and potentially harms — the billions of people of color on the planet. Lack of diversity occurs at all levels of the pharmaceutical ecosystem, from the makeup of C-suite and research staffs to participation in clinical trials.

Drug Development 286

Drug Development 286

Advertisement

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

pharmaphorum

AUGUST 22, 2024

Discover how digital therapeutics (DTx) have evolved in the wake of COVID-19, and how they are changing the landscape of healthcare. Explore the fall and rise of DTx and their potential impact on patient care.

115

115

STAT

AUGUST 22, 2024

Over a year after Pear Therapeutics filed for bankruptcy and shut down, its smartphone apps for people with substance use disorder and opioid use disorder are again available to patients.  After acquiring Pear’s Food and Drug Administration-cleared apps, called reSET and reSET-O,in December 2023 , virtual addiction treatment company PursueCare this month began offering them to its patients.

272

272

Outsourcing Pharma

AUGUST 22, 2024

In the rapidly evolving field of drug discovery, Melanie Adams-Cioaba stands at the forefront, leading transformative advancements in cryo-electron microscopy (cryo-EM) at Thermo Fisher Scientific.

108

108

STAT

AUGUST 22, 2024

Good morning, Pharmalittle fans! Adam Feuerstein here, filling in for Ed. I drink my morning coffee from a heavy, thick diner mug. I suggest you do the same. Here’s some news for your Thursday morning. … Eisai and Biogen secured approval in the U.K. for their Alzheimer’s treatment, Leqembi, but at the same time, the U.K.’s cost-effectiveness watchdog agency issued draft guidance that said the drug’s limited benefits do not justify its costs, STAT reports.

Vaccines 226

Vaccines 226

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

Express Pharma

AUGUST 22, 2024

The US Food and Drug Administration approved and granted emergency use authorisation (EUA) for updated mRNA COVID-19 vaccines (2024-2025 formula) to include a monovalent (single) component that corresponds to the Omicron variant KP.2 strain of SARS-CoV-2. The mRNA COVID-19 vaccines have been updated with this formula to more closely target currently circulating variants and provide better protection against serious consequences of COVID-19, including hospitalisation and death.

Vaccines 105

Vaccines 105

STAT

AUGUST 22, 2024

What does the hiring of a well-known industry dealmaker mean for the future of BioMarin Pharmaceuticals? Can Eli Lilly’s blockbuster obesity medicine lower the risk of diabetes? And will Recursion Pharma, the AI drug developer, live up to all the hype? We discuss all that and more on this week’s episode of “The Readout LOUD.

Diabetes 214

Diabetes Drug Development 214

The Guardian - Pharmaceutical Industry

AUGUST 22, 2024

Decision by Nice to rule out drug being available on NHS comes despite medicines licensing body giving green light The UK’s health regulator has rejected a drug that can slow the progression of Alzheimer’s disease, saying its benefits are too small to justify the costs of the therapy and close monitoring of patients for signs of “serious side-effects”.

100

100

Express Pharma

AUGUST 22, 2024

India’s healthcare sector is undergoing a surge in digital transformation, driven by a strong digital infrastructure and a growing economy. According to the latest ‘SME Digital Insights’ study by Tata Tele Business Services (TTBS) in collaboration with Cyber Media Research (CMR), 33 per cent of healthcare SMEs recognise the potential of big data analytics to enhance diagnostics, while 31 per cent see artificial intelligence (AI) as a valuable tool for streamlining operations and accelerating dr

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies 105

Advertisement

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

The Pharmacist

AUGUST 22, 2024

The UK medicines regulator has approved lecanemab – the first drug shown to slow cognitive decline in patients in the early stages of Alzheimer’s – but NICE said it was too costly for the NHS. NICE’s draft guidance, published today, has been put out for a four-week consultation after the committee concluded the benefits of […] The post NICE rules Alzheimer’s-slowing drug lecanemab too expensive for NHS appeared first on The Pharmacist.

96

96

pharmaphorum

AUGUST 22, 2024

BioMarin names Amgen's Greg Friberg to lead its R&D and former Roche exec James Sabry as its chief dealmaker amid a strategy change

111

111

Express Pharma

AUGUST 22, 2024

Alkem MedTech, a wholly-owned subsidiary of Alkem Laboratories has entered into an agreement with Exactech, a global medical device company headquartered in Gainesville, Florida, USA, to manufacture and market Exactech’s large joint replacement implants in India. Exactech develops, manufactures and markets joint replacement implants, surgical instruments and smart technologies that enhance surgeons’ ability to improve patients’ mobility worldwide.

98

98

Pharmaceutical Technology

AUGUST 22, 2024

Packaging experts discuss emerging challenges in secondary packaging design for injectables that balance sustainability with end-user needs.

Packaging 98

Packaging 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Pharma Times

AUGUST 22, 2024

200,000 people in the UK have what is considered a ‘hidden’ lung condition

122

122

Pharmaceutical Commerce

AUGUST 22, 2024

The unveiling of the microbial fermentation manufacturing plant is headlined by a $131 million financial commitment.

105

105

The Pharmacist

AUGUST 22, 2024

A consultation into the standardisation of pack sizes of oral nutritional supplements (ONS) has highlighted the potential for prescribing errors, patient safety risks, increased waste and cost, and increased workload for community pharmacists under the current system. The Advisory Committee on Borderline Substances (ACBS) has decided to explore these concerns before recommending any action on […] The post Oral nutritional supplement errors impact pharmacy workload appeared first on The Pha

85

85

pharmaphorum

AUGUST 22, 2024

BMS looks ahead to April verdict from FDA on Opdivo/Yervoy combination as first-line treatment for unresectable hepatocellular carcinoma.

105

105

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management

Express Pharma

AUGUST 22, 2024

Eugia Pharma, a wholly-owned subsidiary of Hyderabad-based Aurobindo Pharma received a warning letter from the USFDA. Eugia’s facility at Pashamylaram near Hyderabad was inspected between January 22 to February 2, 2024, after which serevral observations were issued. Subsequently, the company received Official Action Indicated (OAI) status in May 2024.

102

102

Pharma Times

AUGUST 22, 2024

The grant will support clinical trials of rare disease therapy for leukodystrophy

107

107

Express Pharma

AUGUST 22, 2024

Johnson & Johnson announced that the US Food and Drug Administration (FDA) approved Rybrevant (amivantamab-vmjw) plus Lazcluze (lazertinib) for the first-line treatment of adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 19 deletions or exon 21 L858R substitution mutations, as detected by an FDA-approved test.

Chemotherapy 96

Chemotherapy Immunity Immunization 96

pharmaphorum

AUGUST 22, 2024

UK is first European country to approve Eisai and Biogen's Alzheimer's drug Leqembi, after EU advisors say safety concerns outweigh its benefits.

94

94

PharmaTech

AUGUST 22, 2024

In this episode of the Ask the Expert video series, Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Siegfried Schmitt, vice president, Technical at Parexel, discuss submitting biologics license applications and working with suppliers.

64

64